Thermo Fisher Scientific ... (TMO)

NYSE: TMO · Real-Time Price · USD

419.83

-9.17 (-2.14%)

At close: May 01, 2025, 3:59 PM

422.01

0.52%

Pre-market: May 02, 2025, 05:08 AM EDT

Thermo Fisher Scientific Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	6.34B	6B	6.96B	7.73B	6.38B	3.7B	2.94B	2.23B	2.03B
Depreciation & Amortization	3.11B	3.41B	3.38B	2.59B	2.33B	2.28B	2.27B	2.03B	1.76B
Stock-Based Compensation	301M	278M	307M	230M	196M	181M	181M	159M	133.5M
Other Working Capital	-334M	-844M	-442M	-768M	1.36B	-202M	-41M	654M	-49.7M
Other Non-Cash Items	463M	564M	550M	957M	340M	-214M	106M	189M	86.3M
Deferred Income Tax	-1.21B	-1.3B	-995M	-406M	-552M	-348M	-419M	-1.09B	-598.2M
Change in Working Capital	-334M	-537M	-1.05B	-1.56B	-395M	-619M	-530M	485M	-248.6M
Operating Cash Flow	8.67B	8.41B	9.15B	9.54B	8.29B	4.97B	4.54B	4B	3.16B
Capital Expenditures	-1.4B	-1.48B	-2.24B	-2.52B	-1.47B	-926M	-758M	-508M	-444.4M
Cash Acquisitions	-3.13B	-3.66B	-39M	-19.39B	-38M	-715M	-536M	-7.23B	-5.19B
Purchase of Investments	-3.4B	n/a	-15M	-8M	n/a	n/a	n/a	-15M	-54.9M
Sales Maturities Of Investments	1.77B	70M	15M	8M	n/a	n/a	n/a	22M	81.2M
Other Investing Acitivies	317M	-73M	123M	-14M	2M	154M	41M	-2M	74.4M
Investing Cash Flow	-5.84B	-5.14B	-2.16B	-21.93B	-1.51B	-1.49B	-1.25B	-7.73B	-5.53B
Debt Repayment	-2.4B	-155M	654M	8.91B	2.75B	-717M	-1.56B	3.03B	4.17B
Common Stock Repurchased	-4B	-3B	-3B	-2B	-1.5B	-1.5B	-500M	-750M	-1.25B
Dividend Paid	-583M	-523M	-455M	-395M	-337M	-297M	-266M	-237M	-238.4M
Other Financial Acitivies	194M	56M	-9M	65M	46M	-604M	85M	1.81B	39.8M
Financial Cash Flow	-6.79B	-3.62B	-2.81B	6.58B	959M	-3.12B	-2.24B	3.85B	2.86B
Net Cash Flow	-4.06B	-440M	4.05B	-5.84B	7.91B	305M	756M	550M	334.1M
Free Cash Flow	7.27B	6.93B	6.91B	7.02B	6.82B	4.05B	3.79B	3.5B	2.71B